Evidence map›Paper›PMID 40691513›Full record

ArticleEuropean radiology2026

Advances in IPMN imaging: deep learning-enhanced HASTE improves lesion assessment.

Johannes Kolck, Fabio Pivetta, Clarissa Hosse, Haoyin Cao, Uli Fehrenbach, Thomas Malinka, Moritz Wagner, Thula Walter-Rittel, Dominik Geisel

Abstract read
In one paragraph

Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Johannes KolckCharité-Universitätsmedizin Berlin, Department of Radiology, Berlin, Germany. Johannes.kolck@charite.de.ORCID http://orcid.org/0000-0001-9843-2247
Fabio PivettaCharité-Universitätsmedizin Berlin, Department of Radiology, Berlin, Germany.
Clarissa HosseCharité-Universitätsmedizin Berlin, Department of Radiology, Berlin, Germany.
Haoyin CaoCharité-Universitätsmedizin Berlin, Department of Radiology, Berlin, Germany.
Uli FehrenbachCharité-Universitätsmedizin Berlin, Department of Radiology, Berlin, Germany.
Thomas MalinkaCharité-Universitätsmedizin Berlin, Department of Surgery CCM/CVK, Berlin, Germany.
Moritz WagnerCharité-Universitätsmedizin Berlin, Department of Radiology, Berlin, Germany.
Thula Walter-Rittel *Charité-Universitätsmedizin Berlin, Department of Radiology, Berlin, Germany.
Dominik Geisel *Charité-Universitätsmedizin Berlin, Department of Radiology, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe prevalence of asymptomatic pancreatic cysts is increasing due to advances in imaging techniques. Among these, intraductal papillary mucinous neoplasms (IPMNs) are most common, with potential for malignant transformation, often necessitating close follow-up. This study evaluates novel MRI techniques for the assessment of IPMN. MATERIALS AND

methodsFrom May to December 2023, 59 patients undergoing abdominal MRI were retrospectively enrolled. Examinations were conducted on 3-Tesla scanners using a Deep-Learning Accelerated Half-Fourier Single-Shot Turbo Spin-Echo (HASTE

resultsHASTE

conclusionHASTE KEY POINTS: Question Are there advantages of deep-learning-accelerated MRI in imaging and assessing intraductal papillary mucinous neoplasms (IPMN)? Findings Deep-Learning Accelerated Half-Fourier Single-Shot Turbo Spin-Echo (HASTE

Indexed as

Deep LearningMagnetic Resonance ImagingPancreatic Intraductal NeoplasmsPancreatic NeoplasmsAdultAgedAged, 80 and overFemaleHumansImage Interpretation, Computer-AssistedMaleMiddle AgedRetrospective StudiesDeep learning, Half-Fourier single-shot turbo spin-echo (HASTE)Diagnostic confidenceIntraductal papillary mucinous neoplasms (IPMN)Magnetic resonance imaging (MRI)

Identifiers

PMID40691513
PMCPMC12712008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.